Table 1 Clinical information Patient ID... | American Society of Hematology

Table 1

Clinical information

Patient ID	Sex/age, y	Source	Percentage of blasts	Stage	Immunophenotype	Cytogenetics
1345	F/5	BM	95	D	CD10⁺	45 XX dup(1)(q42 q25), del(3)(q21), −9, del(9)(p22), t(18;20)(q21q13.1)
1999	F/14	BM	94	D	CD10⁺CD34⁻	46 XX
0398	M/15	BM	96	R	CD10⁻CD34⁺	46 XY add(3)(q29) t(14:19)(q32p13)
1196	F/8	BM	NA	D	CD10⁺CD34⁻	46 XX −19,del(19), t(1;19)(q23p13)
2032	M/12	BM	NA	D	CD10⁺CD34⁻	46 XY add (9)(p24), del(9)(p21), del(13)(q11q21), der(19) t(1;19)(q23;p13)

Patient ID	Sex/age, y	Source	Percentage of blasts	Stage	Immunophenotype	Cytogenetics
1345	F/5	BM	95	D	CD10⁺	45 XX dup(1)(q42 q25), del(3)(q21), −9, del(9)(p22), t(18;20)(q21q13.1)
1999	F/14	BM	94	D	CD10⁺CD34⁻	46 XX
0398	M/15	BM	96	R	CD10⁻CD34⁺	46 XY add(3)(q29) t(14:19)(q32p13)
1196	F/8	BM	NA	D	CD10⁺CD34⁻	46 XX −19,del(19), t(1;19)(q23p13)
2032	M/12	BM	NA	D	CD10⁺CD34⁻	46 XY add (9)(p24), del(9)(p21), del(13)(q11q21), der(19) t(1;19)(q23;p13)

D indicates diagnosis; NA, not available; and R, relapse.